President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

The new high-precision radiotherapy cuts the number of sessions required from 20 to five.

Immunotherapy: Hope, Hurdles, and a Clever Disguise Immunotherapies stand as one of the most promising paths in modern cancer treatment. Their main goal? To help the body’s own immune system hunt down ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The "striking" findings showed an ...

ABOUT IT. PROSTATE CANCER. IT CAN BE A TOPIC MANY OF US TRY TO AVOID, ESPECIALLY WHEN IT COMES TO HOW YOU HAVE TO SCREEN FOR IT. BUT DURING THIS NATIONAL MEN’S HEALTH AWARENESS MONTH, DOCTORS HAVE A ...

Add Yahoo as a preferred source to see more of our stories on Google. FARRELL, Pa. (WKBN) — UPMC announced Tuesday that it will begin offering advanced prostate cancer treatment closer to home so ...

Prostate cancer remains one of the most common cancers among men with an estimated 1.5 million cases diagnosed worldwide. While hormone therapy has long been the cornerstone of treatment for ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...